{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:57:31Z","timestamp":1786982251136,"version":"build-2736575974"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T00:00:00Z","timestamp":1672185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-022-03056-7","type":"journal-article","created":{"date-parts":[[2022,12,28]],"date-time":"2022-12-28T03:02:54Z","timestamp":1672196574000},"page":"1489-1511","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Non-coding RNAs as potential biomarkers of gallbladder cancer"],"prefix":"10.1007","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7387-7477","authenticated-orcid":false,"given":"Yan","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyue","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,28]]},"reference":[{"issue":"8","key":"3056_CR1","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1245\/s10434-020-08654-9","volume":"27","author":"AC Gamboa","year":"2020","unstructured":"Gamboa AC, Maithel SK. The landmark series: gallbladder cancer. Ann Surg Oncol. 2020;27(8):2846\u201358.","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"3056_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/nrc1429","volume":"4","author":"II Wistuba","year":"2004","unstructured":"Wistuba II, Gazdar AF. Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer. 2004;4(9):695\u2013706.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3056_CR3","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.soc.2019.06.005","volume":"28","author":"L Cherkassky","year":"2019","unstructured":"Cherkassky L, D\u2019Angelica M. Gallbladder cancer: managing the incidental diagnosis. Surg Oncol Clin N Am. 2019;28(4):619\u201330.","journal-title":"Surg Oncol Clin N Am"},{"key":"3056_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrfmmm.2019.111674","volume":"816","author":"SK Mishra","year":"2019","unstructured":"Mishra SK, Kumari N, Krishnani N. Molecular pathogenesis of gallbladder cancer: An update. Mutat Res. 2019;816: 111674.","journal-title":"Mutat Res"},{"issue":"4","key":"3056_CR5","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/j.1440-1746.2011.07048.x","volume":"27","author":"U Dutta","year":"2012","unstructured":"Dutta U. Gallbladder cancer: can newer insights improve the outcome? J Gastroenterol Hepatol. 2012;27(4):642\u201353.","journal-title":"J Gastroenterol Hepatol"},{"issue":"43","key":"3056_CR6","doi-asserted-by":"publisher","first-page":"12211","DOI":"10.3748\/wjg.v21.i43.12211","volume":"21","author":"TO Goetze","year":"2015","unstructured":"Goetze TO. Gallbladder carcinoma: Prognostic factors and therapeutic options. World J Gastroenterol. 2015;21(43):12211\u20137.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"3056_CR7","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archsurg.2009.46","volume":"144","author":"IT Konstantinidis","year":"2009","unstructured":"Konstantinidis IT, Deshpande V, Genevay M, Berger D, Fernandez-del Castillo C, Tanabe KK, et al. Trends in presentation and survival for gallbladder cancer during a period of more than 4 decades: a single-institution experience. Arch Surg. 2009;144(5):441\u20137.","journal-title":"Arch Surg"},{"issue":"3","key":"3056_CR8","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jamcollsurg.2008.02.031","volume":"207","author":"NG Coburn","year":"2008","unstructured":"Coburn NG, Cleary SP, Tan JC, Law CH. Surgery for gallbladder cancer: a population-based analysis. J Am Coll Surg. 2008;207(3):371\u201382.","journal-title":"J Am Coll Surg"},{"issue":"5","key":"3056_CR9","first-page":"221","volume":"3","author":"M Raki\u0107","year":"2014","unstructured":"Raki\u0107 M, Patrlj L, Kopljar M, Kli\u010dek R, Kolovrat M, Loncar B, et al. Gallbladder cancer. Hepatobiliary Surg Nutr. 2014;3(5):221\u20136.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"3","key":"3056_CR10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.bbrc.2019.06.121","volume":"516","author":"K Gong","year":"2019","unstructured":"Gong K, Gong ZJ, Lu PX, Ni XL, Shen S, Liu H, et al. PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma. Biochem Biophys Res Commun. 2019;516(3):983\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3056_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.suronc.2012.12.001","volume":"22","author":"CH Caldow Pilgrim","year":"2013","unstructured":"Caldow Pilgrim CH, Groeschl RT, Quebbeman EJ, Gamblin TC. Recent advances in systemic therapies and radiotherapy for gallbladder cancer. Surg Oncol. 2013;22(1):61\u20137.","journal-title":"Surg Oncol"},{"key":"3056_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2021.103328","volume":"163","author":"AA Azizi","year":"2021","unstructured":"Azizi AA, Lamarca A, McNamara MG, Valle JW. Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis. Crit Rev Oncol Hematol. 2021;163: 103328.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"3056_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1186\/s12885-020-07334-x","volume":"20","author":"A Sachan","year":"2020","unstructured":"Sachan A, Saluja SS, Nekarakanti PK, Nimisha MB, Nag HH, et al. Raised CA19\u20139 and CEA have prognostic relevance in gallbladder carcinoma. BMC Cancer. 2020;20(1):826.","journal-title":"BMC Cancer"},{"issue":"11","key":"3056_CR14","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.hpb.2017.06.011","volume":"19","author":"Z Wen","year":"2017","unstructured":"Wen Z, Si A, Yang J, Yang P, Yang X, Liu H, et al. Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma. HPB (Oxford). 2017;19(11):951\u20136.","journal-title":"HPB (Oxford)"},{"issue":"3","key":"3056_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1002\/bjs.10415","volume":"104","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Passot G, Aloia TA, Chun YS, Javle M, Lee JE, et al. Prognostic value of carbohydrate antigen 19\u20139 in patients undergoing resection of biliary tract cancer. Br J Surg. 2017;104(3):267\u201377.","journal-title":"Br J Surg"},{"issue":"2","key":"3056_CR16","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1477-2574.2009.00149.x","volume":"12","author":"I Hatzaras","year":"2010","unstructured":"Hatzaras I, Schmidt C, Muscarella P, Melvin WS, Ellison EC, Bloomston M. Elevated CA 19\u20139 portends poor prognosis in patients undergoing resection of biliary malignancies. HPB (Oxford). 2010;12(2):134\u20138.","journal-title":"HPB (Oxford)"},{"issue":"5","key":"3056_CR17","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1007\/s10620-017-4506-1","volume":"62","author":"BC Richard","year":"2017","unstructured":"Richard BC. Non-coding RNA: It\u2019s Not Junk. Dig Dis Sci. 2017;62(5):1107\u20139.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"3056_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41392-020-0162-6","volume":"5","author":"XY Xue","year":"2020","unstructured":"Xue XY, Liu YX, Wang C, Gu XJ, Xue ZQ, Zang XL, et al. Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma. Signal Transduct Target Ther. 2020;5(1):77.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3056_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrc.2017.99","volume":"18","author":"E Anastasiadou","year":"2018","unstructured":"Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5\u201318.","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"3056_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2019.10.017","volume":"179","author":"FJ Slack","year":"2019","unstructured":"Slack FJ, Chinnaiyan AM. The role of non-coding RNAs in oncology. Cell. 2019;179(5):1033\u201355.","journal-title":"Cell"},{"issue":"2","key":"3056_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136(2):215\u201333.","journal-title":"Cell"},{"issue":"1","key":"3056_CR22","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1101\/gr.082701.108","volume":"19","author":"RC Friedman","year":"2009","unstructured":"Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19(1):92\u2013105.","journal-title":"Genome Res"},{"issue":"2","key":"3056_CR23","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202009045","volume":"220","author":"MC Bridges","year":"2021","unstructured":"Bridges MC, Daulagala AC, Kourtidis A. LNCcation: lncRNA localization and function. J Cell Biol. 2021;220(2): e202009045.","journal-title":"J Cell Biol"},{"issue":"11","key":"3056_CR24","doi-asserted-by":"publisher","first-page":"604","DOI":"10.5483\/BMBRep.2012.45.11.227","volume":"45","author":"R Maruyama","year":"2012","unstructured":"Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45(11):604\u201311.","journal-title":"BMB Rep"},{"issue":"1","key":"3056_CR25","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13045-019-0776-8","volume":"12","author":"T Yu","year":"2019","unstructured":"Yu T, Wang Y, Fan Y, Fang N, Wang T, Xu T, et al. CircRNAs in cancer metabolism: a review. J Hematol Oncol. 2019;12(1):90.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3056_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-020-1135-7","volume":"19","author":"M Lei","year":"2020","unstructured":"Lei M, Zheng G, Ning Q, Zheng J, Dong D. Translation and functional roles of circular RNAs in human cancer. Mol Cancer. 2020;19(1):30.","journal-title":"Mol Cancer"},{"issue":"1","key":"3056_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cell.2013.03.019","volume":"153","author":"J Lieberman","year":"2013","unstructured":"Lieberman J, Slack F, Pandolfi PP, Chinnaiyan A, Agami R, Mendell JT. Noncoding RNAs and cancer. Cell. 2013;153(1):9\u201310.","journal-title":"Cell"},{"issue":"5","key":"3056_CR28","first-page":"780","volume":"18","author":"G Militello","year":"2017","unstructured":"Militello G, Weirick T, John D, D\u00f6ring C, Dimmeler S, Uchida S. Screening and validation of lncRNAs and circRNAs as miRNA sponges. Brief Bioinform. 2017;18(5):780\u20138.","journal-title":"Brief Bioinform"},{"issue":"4","key":"3056_CR29","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/1878-0261.12468","volume":"13","author":"L Verduci","year":"2019","unstructured":"Verduci L, Strano S, Yarden Y, Blandino G. The circRNA-microRNA code: emerging implications for cancer diagnosis and treatment. Mol Oncol. 2019;13(4):669\u201380.","journal-title":"Mol Oncol"},{"issue":"3","key":"3056_CR30","first-page":"2735","volume":"15","author":"W Tan","year":"2018","unstructured":"Tan W, Liu B, Qu S, Liang G, Luo W, Gong C. MicroRNAs and cancer: key paradigms in molecular therapy. Oncol Lett. 2018;15(3):2735\u201342.","journal-title":"Oncol Lett"},{"issue":"5","key":"3056_CR31","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3322\/caac.21244","volume":"64","author":"I Berindan-Neagoe","year":"2014","unstructured":"Berindan-Neagoe I, MonroigPdel C, Pasculli B, Calin GA. MicroRNAome genome: a treasure for cancer diagnosis and therapy. CA Cancer J Clin. 2014;64(5):311\u201336.","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"3056_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.17219\/acem\/134833","volume":"30","author":"L Tong","year":"2021","unstructured":"Tong L, Cheng J, Zuo H, Li J. MicroRNA-197 promotes proliferation and inhibits apoptosis of gallbladder cancer cells by targeting insulin-like growth factor-binding protein 3. Adv Clin Exp Med. 2021;30(7):661\u201372.","journal-title":"Adv Clin Exp Med"},{"issue":"4","key":"3056_CR33","doi-asserted-by":"publisher","first-page":"10691","DOI":"10.1080\/21655979.2022.2065951","volume":"13","author":"X Hu","year":"2022","unstructured":"Hu X, Zhang J, Bu J, Yang K, Xu S, Pan M, et al. MiR-4733-5p promotes gallbladder carcinoma progression via directly targeting kruppel like factor 7. Bioengineered. 2022;13(4):10691\u2013706.","journal-title":"Bioengineered"},{"issue":"1","key":"3056_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3892\/or.2013.2443","volume":"30","author":"H Kono","year":"2013","unstructured":"Kono H, Nakamura M, Ohtsuka T, Nagayoshi Y, Mori Y, Takahata S, et al. High expression of microRNA-155 is associated with the aggressive malignant behavior of gallbladder carcinoma. Oncol Rep. 2013;30(1):17\u201324.","journal-title":"Oncol Rep"},{"issue":"3","key":"3056_CR35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol. 2019;29(3):212\u201326.","journal-title":"Trends Cell Biol"},{"issue":"7702","key":"3056_CR36","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556(7702):463\u20138.","journal-title":"Nature"},{"issue":"3","key":"3056_CR37","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jhep.2013.04.034","volume":"59","author":"Y Chang","year":"2013","unstructured":"Chang Y, Liu C, Yang J, Liu G, Feng F, Tang J, et al. MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol. 2013;59(3):518\u201327.","journal-title":"J Hepatol"},{"issue":"17","key":"3056_CR38","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.21037\/atm-21-2013","volume":"9","author":"F Song","year":"2021","unstructured":"Song F, Yang Z, Li L, Wei Y, Tang X, Liu S, et al. MiR-552-3p promotes malignant progression of gallbladder carcinoma by reactivating the Akt\/\u03b2-catenin signaling pathway due to inhibition of the tumor suppressor gene RGMA. Ann Transl Med. 2021;9(17):1374.","journal-title":"Ann Transl Med"},{"issue":"3","key":"3056_CR39","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3892\/ol.2021.12461","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, Hu Z, Wen C, Liao Q, He B, Peng J, et al. MicroRNA-182 promotes epithelial-mesenchymal transition by targeting FOXN3 in gallbladder cancer. Oncol Lett. 2021;21(3):200.","journal-title":"Oncol Lett"},{"issue":"2","key":"3056_CR40","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/WNR.0000000000000506","volume":"27","author":"J Li","year":"2016","unstructured":"Li J, Zhu S, Tong J, Hao H, Yang J, Liu Z, et al. Suppression of lactate dehydrogenase A compromises tumor progression by downregulation of the Warburg effect in glioblastoma. NeuroReport. 2016;27(2):110\u20135.","journal-title":"NeuroReport"},{"issue":"5","key":"3056_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS. Fundamentals of cancer metabolism. Sci Adv. 2016;2(5): e1600200.","journal-title":"Sci Adv"},{"issue":"16","key":"3056_CR42","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1158\/0008-5472.CAN-15-0108","volume":"75","author":"NV Rajeshkumar","year":"2015","unstructured":"Rajeshkumar NV, Dutta P, Yabuuchi S, de Wilde RF, Martinez GV, Le A, et al. Therapeutic targeting of the warburg effect in pancreatic cancer relies on an absence of p53 function. Cancer Res. 2015;75(16):3355\u201364.","journal-title":"Cancer Res"},{"issue":"6","key":"3056_CR43","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/mc.22799","volume":"57","author":"Y He","year":"2018","unstructured":"He Y, Chen X, Yu Y, Li J, Hu Q, Xue C, et al. LDHA is a direct target of miR-30d-5p and contributes to aggressive progression of gallbladder carcinoma. Mol Carcinog. 2018;57(6):772\u201383.","journal-title":"Mol Carcinog"},{"issue":"1","key":"3056_CR44","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.prp.2018.10.013","volume":"215","author":"CB Hua","year":"2019","unstructured":"Hua CB, Song SB, Ma HL, Li XZ. MiR-1-5p is down-regulated in gallbladder carcinoma and suppresses cell proliferation, migration and invasion by targeting Notch2. Pathol Res Pract. 2019;215(1):200\u20138.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"3056_CR45","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41419-017-0258-2","volume":"9","author":"YP Jin","year":"2018","unstructured":"Jin YP, Hu YP, Wu XS, Wu YS, Ye YY, Li HF, et al. miR-143-3p targeting of ITGA6 suppresses tumour growth and angiogenesis by downregulating PLGF expression via the PI3K\/AKT pathway in gallbladder carcinoma. Cell Death Dis. 2018;9(2):182.","journal-title":"Cell Death Dis"},{"issue":"4","key":"3056_CR46","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1002\/kjm2.12323","volume":"37","author":"XL Li","year":"2021","unstructured":"Li XL, Li SZ, Wu CX, Xing XH. miR-188-5p inhibits proliferation, migration, and invasion in gallbladder carcinoma by targeting Wnt2b and Smad2. Kaohsiung J Med Sci. 2021;37(4):294\u2013304.","journal-title":"Kaohsiung J Med Sci"},{"issue":"5","key":"3056_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0126499","volume":"10","author":"F Ma","year":"2015","unstructured":"Ma F, Zhang M, Gong W, Weng M, Quan Z. MiR-138 suppresses cell proliferation by targeting bag-1 in gallbladder Carcinoma. PLoS ONE. 2015;10(5): e0126499.","journal-title":"PLoS ONE"},{"issue":"3","key":"3056_CR48","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/cdd.2016.146","volume":"24","author":"YJ Shu","year":"2017","unstructured":"Shu YJ, Bao RF, Jiang L, Wang Z, Wang XA, Zhang F, et al. MicroRNA-29c-5p suppresses gallbladder carcinoma progression by directly targeting CPEB4 and inhibiting the MAPK pathway. Cell Death Differ. 2017;24(3):445\u201357.","journal-title":"Cell Death Differ"},{"issue":"1","key":"3056_CR49","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/21691401.2019.1703724","volume":"48","author":"X Zhang","year":"2020","unstructured":"Zhang X, Zhang L, Chen M, Liu D. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression. Artif Cells Nanomed Biotechnol. 2020;48(1):315\u201324.","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"3056_CR50","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1080\/15384101.2022.2042775","volume":"21","author":"X Yan","year":"2022","unstructured":"Yan X, Yang P, Liu H, Zhao Y, Wu Z, Zhang B. miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR\/AKT signaling. Cell Cycle. 2022;21(11):1166\u201377.","journal-title":"Cell Cycle"},{"issue":"5","key":"3056_CR51","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ng2003","volume":"39","author":"MS Kumar","year":"2007","unstructured":"Kumar MS, Lu J, Mercer KL, Golub TR, Jacks T. Impaired microRNA processing enhances cellular transformation and tumorigenesis. Nat Genet. 2007;39(5):673\u20137.","journal-title":"Nat Genet"},{"issue":"11","key":"3056_CR52","first-page":"6739","volume":"11","author":"WX Xu","year":"2019","unstructured":"Xu WX, Liu Z, Deng F, Wang DD, Li XW, Tian T, et al. MiR-145: a potential biomarker of cancer migration and invasion. Am J Transl Res. 2019;11(11):6739\u201353.","journal-title":"Am J Transl Res"},{"key":"3056_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1515\/biol-2018-0027","volume":"13","author":"Y Yuan","year":"2018","unstructured":"Yuan Y, Yang Z, Zou Q. MiRNA-145 induces apoptosis in a gallbladder carcinoma cell line by targeting DFF45. Open Life Sci. 2018;13:227\u201335.","journal-title":"Open Life Sci"},{"key":"3056_CR54","first-page":"1770643","volume":"2022","author":"W Zhao","year":"2022","unstructured":"Zhao W, Gong Y, Chen Y. MRNA profiling involved in triggering of STAT1 with regulatory involvement of IRF7, PTPRF, and miR-145p in patients suffering from gall bladder Carcinoma. J Healthc Eng. 2022;2022:1770643.","journal-title":"J Healthc Eng"},{"issue":"1","key":"3056_CR55","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1038\/s41598-019-40857-3","volume":"9","author":"B Goeppert","year":"2019","unstructured":"Goeppert B, Truckenmueller F, Ori A, Fritz V, Albrecht T, Fraas A, et al. Profiling of gallbladder carcinoma reveals distinct miRNA profiles and activation of STAT1 by the tumor suppressive miRNA-145-5p. Sci Rep. 2019;9(1):4796.","journal-title":"Sci Rep"},{"issue":"1","key":"3056_CR56","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3892\/mmr.2015.3461","volume":"12","author":"J Cai","year":"2015","unstructured":"Cai J, Xu L, Cai Z, Wang J, Zhou B, Hu H. MicroRNA-146b-5p inhibits the growth of gallbladder carcinoma by targeting epidermal growth factor receptor. Mol Med Rep. 2015;12(1):1549\u201355.","journal-title":"Mol Med Rep"},{"issue":"4","key":"3056_CR57","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3892\/or.2021.7966","volume":"45","author":"B Ouyang","year":"2021","unstructured":"Ouyang B, Pan N, Zhang H, Xing C, Ji W. miR-146b-5p inhibits tumorigenesis and metastasis of gallbladder cancer by targeting Toll-like receptor 4 via the nuclear factor-\u03baB pathway. Oncol Rep. 2021;45(4):15.","journal-title":"Oncol Rep"},{"issue":"16","key":"3056_CR58","doi-asserted-by":"publisher","first-page":"22339","DOI":"10.18632\/oncotarget.7970","volume":"7","author":"RF Bao","year":"2016","unstructured":"Bao RF, Shu YJ, Hu YP, Wang XA, Zhang F, Liang HB, et al. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK\/Erk and Smad pathways in gallbladder carcinoma. Oncotarget. 2016;7(16):22339\u201354.","journal-title":"Oncotarget"},{"key":"3056_CR59","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-015-4308-z","author":"W Lu","year":"2015","unstructured":"Lu W, Zhang Y, Zhou L, Wang X, Mu J, Jiang L, et al. miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma. Tumour Biol. 2015. https:\/\/doi.org\/10.1007\/s13277-015-4308-z.","journal-title":"Tumour Biol"},{"key":"3056_CR60","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.biochi.2017.10.027","volume":"146","author":"N Wang","year":"2018","unstructured":"Wang N, Xiang X, Chen K, Liu P, Zhu A. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma. Biochimie. 2018;146:56\u201367.","journal-title":"Biochimie"},{"issue":"1","key":"3056_CR61","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s00535-019-01627-0","volume":"55","author":"K Lu","year":"2020","unstructured":"Lu K, Feng F, Yang Y, Liu K, Duan J, Liu H, et al. High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma. J Gastroenterol. 2020;55(1):51\u201366.","journal-title":"J Gastroenterol"},{"issue":"3","key":"3056_CR62","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/0163-7258(90)90056-8","volume":"48","author":"WB Parker","year":"1990","unstructured":"Parker WB, Cheng YC. Metabolism and mechanism of action of 5-fluorouracil. Pharmacol Ther. 1990;48(3):381\u201395.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"3056_CR63","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1158\/0008-5472.CAN-16-0150","volume":"76","author":"VC Jordan","year":"2016","unstructured":"Jordan VC. A retrospective: on clinical studies with 5-Fluorouracil. Cancer Res. 2016;76(4):767\u20138.","journal-title":"Cancer Res"},{"key":"3056_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111285","volume":"137","author":"C Sethy","year":"2021","unstructured":"Sethy C, Kundu CN. 5-Fluorouracil (5-FU) resistance and the new strategy to enhance the sensitivity against cancer: Implication of DNA repair inhibition. Biomed Pharmacother. 2021;137: 111285.","journal-title":"Biomed Pharmacother"},{"issue":"22","key":"3056_CR65","first-page":"9829","volume":"23","author":"W Wang","year":"2019","unstructured":"Wang W, Chen LC, Qian JY, Zhang Q. MiR-335 promotes cell proliferation by inhibiting MEF2D and sensitizes cells to 5-Fu treatment in gallbladder carcinoma. Eur Rev Med Pharmacol Sci. 2019;23(22):9829\u201339.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"23","key":"3056_CR66","first-page":"12116","volume":"24","author":"YQ Gong","year":"2020","unstructured":"Gong YQ, Ni JL, Fang Q, Li T. MiR-1231 enhances docetaxel sensitivity to gallbladder carcinoma cells by downregulating FOXC2. Eur Rev Med Pharmacol Sci. 2020;24(23):12116\u201323.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"6","key":"3056_CR67","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3322\/canjclin.51.6.349","volume":"51","author":"EC Lazcano-Ponce","year":"2001","unstructured":"Lazcano-Ponce EC, Miquel JF, Mu\u00f1oz N, Herrero R, Ferrecio C, Wistuba II, et al. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin. 2001;51(6):349\u201364.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3056_CR68","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1245\/s10434-017-6139-1","volume":"25","author":"BH Kim","year":"2018","unstructured":"Kim BH, Kwon J, Chie EK, Kim K, Kim YH, Seo DW, et al. Adjuvant chemoradiotherapy is associated with improved survival for patients with resected Gallbladder Carcinoma: a systematic review and meta-analysis. Ann Surg Oncol. 2018;25(1):255\u201364.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"3056_CR69","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jamcollsurg.2010.09.009","volume":"212","author":"JM Butte","year":"2011","unstructured":"Butte JM, Matsuo K, G\u00f6nen M, D\u2019Angelica MI, Waugh E, Allen PJ, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212(1):50\u201361.","journal-title":"J Am Coll Surg"},{"issue":"1","key":"3056_CR70","doi-asserted-by":"publisher","first-page":"111","DOI":"10.21037\/jgo.2017.10.02","volume":"9","author":"A Neyaz","year":"2018","unstructured":"Neyaz A, Husain N, Gupta S, Kumari S, Arora A, Awasthi NP, et al. Investigation of targetable predictive and prognostic markers in gallbladder carcinoma. J Gastrointest Oncol. 2018;9(1):111\u201325.","journal-title":"J Gastrointest Oncol"},{"issue":"3","key":"3056_CR71","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1080\/15384101.2021.1874694","volume":"20","author":"ZB Jiang","year":"2021","unstructured":"Jiang ZB, Ma BQ, Feng Z, Liu SG, Gao P, Yan HT. miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients. Cell Cycle. 2021;20(3):308\u201319.","journal-title":"Cell Cycle"},{"issue":"6","key":"3056_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12510","volume":"51","author":"J Chen","year":"2018","unstructured":"Chen J, Yu Y, Chen X, He Y, Hu Q, Li H, et al. MiR-139-5p is associated with poor prognosis and regulates glycolysis by repressing PKM2 in gallbladder carcinoma. Cell Prolif. 2018;51(6): e12510.","journal-title":"Cell Prolif"},{"issue":"2","key":"3056_CR73","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1007\/s13277-013-1207-z","volume":"35","author":"K Jin","year":"2014","unstructured":"Jin K, Xiang Y, Tang J, Wu G, Li J, Xiao H, et al. miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells. Tumour Biol. 2014;35(2):1503\u201310.","journal-title":"Tumour Biol"},{"key":"3056_CR74","first-page":"1625","volume":"6","author":"HH Peng","year":"2013","unstructured":"Peng HH, Zhang YD, Gong LS, Liu WD, Zhang Y. Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther. 2013;6:1625\u201330.","journal-title":"Onco Targets Ther"},{"issue":"2","key":"3056_CR75","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.18632\/aging.202444","volume":"13","author":"B Zhang","year":"2021","unstructured":"Zhang B, Cui H, Sun Y, Wang X, Jia Q, Li J, et al. Up-regulation of miR-204 inhibits proliferation, invasion and apoptosis of gallbladder cancer cells by targeting Notch2. Aging (Albany NY). 2021;13(2):2941\u201358.","journal-title":"Aging (Albany NY)"},{"issue":"3","key":"3056_CR76","first-page":"518","volume":"21","author":"YP Lv","year":"2017","unstructured":"Lv YP, Shi W, Liu HX, Kong XJ, Dai DL. Identification of miR-146b-5p in tissues as a novel biomarker for prognosis of gallbladder carcinoma. Eur Rev Med Pharmacol Sci. 2017;21(3):518\u201322.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"3","key":"3056_CR77","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrg2521","volume":"10","author":"TR Mercer","year":"2009","unstructured":"Mercer TR, Dinger ME, Mattick JS. Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009;10(3):155\u20139.","journal-title":"Nat Rev Genet"},{"issue":"11","key":"3056_CR78","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","volume":"1839","author":"G Yang","year":"2014","unstructured":"Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta. 2014;1839(11):1097\u2013109.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"3056_CR79","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29(4):452\u201363.","journal-title":"Cancer Cell"},{"issue":"5","key":"3056_CR80","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.3892\/ol.2017.5893","volume":"13","author":"J Wang","year":"2017","unstructured":"Wang J, Liu H, Shen X, Wang Y, Zhang D, Shen S, et al. Long non-coding RNA expression profiles in gallbladder carcinoma identified using microarray analysis. Oncol Lett. 2017;13(5):3508\u201316.","journal-title":"Oncol Lett"},{"issue":"29","key":"3056_CR81","doi-asserted-by":"publisher","first-page":"47957","DOI":"10.18632\/oncotarget.18204","volume":"8","author":"Q Cai","year":"2017","unstructured":"Cai Q, Jin L, Wang S, Zhou D, Wang J, Tang Z, et al. Long non-coding RNA UCA1 promotes gallbladder cancer progression by epigenetically repressing p21 and E-cadherin expression. Oncotarget. 2017;8(29):47957\u201368.","journal-title":"Oncotarget"},{"issue":"6","key":"3056_CR82","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4161\/cbt.28584","volume":"15","author":"XS Wu","year":"2014","unstructured":"Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding Q, et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK\/MAPK pathway. Cancer Biol Ther. 2014;15(6):806\u201314.","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"3056_CR83","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1016\/j.jhep.2016.01.019","volume":"64","author":"X Wang","year":"2016","unstructured":"Wang X, Sun W, Shen W, Xia M, Chen C, Xiang D, et al. Long non-coding RNA DILC regulates liver cancer stem cells via IL-6\/STAT3 axis. J Hepatol. 2016;64(6):1283\u201394.","journal-title":"J Hepatol"},{"key":"3056_CR84","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.gene.2018.12.086","volume":"694","author":"C Liang","year":"2019","unstructured":"Liang C, Yang P, Han T, Wang RY, Xing XL, Si AF, et al. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma. Gene. 2019;694:102\u201310.","journal-title":"Gene"},{"issue":"2","key":"3056_CR85","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrc3447","volume":"13","author":"B De Craene","year":"2013","unstructured":"De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer. 2013;13(2):97\u2013110.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"3056_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2022.166431","volume":"1868","author":"R Gundamaraju","year":"2022","unstructured":"Gundamaraju R, Lu W, Paul MK, Jha NK, Gupta PK, Ojha S, et al. Autophagy and EMT in cancer and metastasis: Who controls whom? Biochim Biophys Acta Mol Basis Dis. 2022;1868(9): 166431.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"1","key":"3056_CR87","first-page":"15","volume":"6","author":"SH Wang","year":"2015","unstructured":"Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D, Quan ZW. Upregulation of H19 indicates a poor prognosis in gallbladder carcinoma and promotes epithelial-mesenchymal transition. Am J Cancer Res. 2015;6(1):15\u201326.","journal-title":"Am J Cancer Res"},{"issue":"20","key":"3056_CR88","doi-asserted-by":"publisher","first-page":"33137","DOI":"10.18632\/oncotarget.16561","volume":"8","author":"P Zhang","year":"2017","unstructured":"Zhang P, Cao P, Zhu X, Pan M, Zhong K, He R, et al. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma. Oncotarget. 2017;8(20):33137\u201343.","journal-title":"Oncotarget"},{"issue":"2","key":"3056_CR89","doi-asserted-by":"publisher","first-page":"3104","DOI":"10.18632\/oncotarget.13621","volume":"8","author":"L Yang","year":"2017","unstructured":"Yang L, Cheng X, Ge N, Guo W, Feng F, Wan F. Long non-coding RNA SPRY4-IT1 promotes gallbladder carcinoma progression. Oncotarget. 2017;8(2):3104\u201310.","journal-title":"Oncotarget"},{"issue":"7","key":"3056_CR90","doi-asserted-by":"publisher","first-page":"9875","DOI":"10.1007\/s13277-016-4863-y","volume":"37","author":"B Liu","year":"2016","unstructured":"Liu B, Shen ED, Liao MM, Hu YB, Wu K, Yang P, et al. Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer. Tumour Biol. 2016;37(7):9875\u201386.","journal-title":"Tumour Biol"},{"issue":"10","key":"3056_CR91","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.21037\/tcr-20-1091","volume":"9","author":"JZ Niu","year":"2020","unstructured":"Niu JZ, Liang XC, Xu ZW, Li ZH, Li J, Meng Y, et al. Long non-coding RNA Linc00261 as a novel potential diagnostic and prognostic biomarker for gallbladder cancer. Transl Cancer Res. 2020;9(10):6078\u201385.","journal-title":"Transl Cancer Res"},{"issue":"4","key":"3056_CR92","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.bbrc.2019.10.104","volume":"522","author":"Z Xue","year":"2020","unstructured":"Xue Z, Yang B, Xu Q, Zhu X, Qin G. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma. Biochem Biophys Res Commun. 2020;522(4):952\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"3056_CR93","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cell.2011.07.014","volume":"146","author":"L Salmena","year":"2011","unstructured":"Salmena L, Poliseno L, Tay Y, Kats L, Pandolfil PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353\u20138.","journal-title":"Cell"},{"key":"3056_CR94","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.biochi.2016.11.007","volume":"132","author":"A Khandelwal","year":"2017","unstructured":"Khandelwal A, Malhotra A, Jain M, Vasquez KM, Jain A. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis. Biochimie. 2017;132:152\u201360.","journal-title":"Biochimie"},{"key":"3056_CR95","doi-asserted-by":"publisher","first-page":"12983","DOI":"10.2147\/CMAR.S278719","volume":"12","author":"J Li","year":"2020","unstructured":"Li J, Zhang H, Luo H. Long non-coding RNA OIP5-AS1 contributes to gallbladder cancer cell invasion and migration by miR-143-3p suppression. Cancer Manag Res. 2020;12:12983\u201392.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3056_CR96","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s12957-021-02279-2","volume":"19","author":"Z Lin","year":"2021","unstructured":"Lin Z, Li Y, Shao R, Hu Y, Gao H. LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107\/HMGA1 axis. World J Surg Oncol. 2021;19(1):163.","journal-title":"World J Surg Oncol"},{"issue":"12","key":"3056_CR97","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s12032-021-01594-8","volume":"38","author":"L Su","year":"2021","unstructured":"Su L, Zhang J, Zhang X, Zheng L, Zhu Z. Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma. Med Oncol. 2021;38(12):141.","journal-title":"Med Oncol"},{"issue":"6","key":"3056_CR98","doi-asserted-by":"publisher","first-page":"855","DOI":"10.3892\/ol.2021.13116","volume":"22","author":"Z Sui","year":"2021","unstructured":"Sui Z, Sui X. Long non-coding RNA TMPO-AS1 promotes cell proliferation, migration, invasion and epithelial-to-mesenchymal transition in gallbladder carcinoma by regulating the microRNA-1179\/E2F2 axis. Oncol Lett. 2021;22(6):855.","journal-title":"Oncol Lett"},{"key":"3056_CR99","first-page":"1","volume":"26","author":"X Zhu","year":"2022","unstructured":"Zhu X, Shi C, Hou C. AFAP1-AS1\/Hsa-miR-15a-5p\/Bcl-2 axis is a potential regulator of cancer cell proliferation and apoptosis in gallbladder carcinoma. Nutr Cancer. 2022;26:1\u201312.","journal-title":"Nutr Cancer"},{"key":"3056_CR100","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fonc.2019.00502","volume":"9","author":"C Derderian","year":"2019","unstructured":"Derderian C, Orunmuyi AT, Olapade-Olaopa EO, Ogunwobi OO. PVT1 signaling is a mediator of cancer progression. Front Oncol. 2019;9:502.","journal-title":"Front Oncol"},{"issue":"1","key":"3056_CR101","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12943-019-0947-9","volume":"18","author":"J Chen","year":"2019","unstructured":"Chen J, Yu Y, Li H, Hu Q, Chen X, He Y, et al. Long non-coding RNA PVT1 promotes tumor progression by regulating the miR-143\/HK2 axis in gallbladder cancer. Mol Cancer. 2019;18(1):33.","journal-title":"Mol Cancer"},{"issue":"10","key":"3056_CR102","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41419-020-03080-x","volume":"11","author":"L Jin","year":"2020","unstructured":"Jin L, Cai Q, Wang S, Wang S, Wang J, Quan Z. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation. Cell Death Dis. 2020;11(10):871.","journal-title":"Cell Death Dis"},{"issue":"3","key":"3056_CR103","first-page":"875","volume":"34","author":"K Liu","year":"2020","unstructured":"Liu K, Xu Q. LncRNA PVT1 regulates gallbladder cancer progression through miR-30d-5p. J Biol Regul Homeost Agents. 2020;34(3):875\u201383.","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"3056_CR104","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/0008-5472.CAN-10-2483","volume":"71","author":"MC Tsai","year":"2011","unstructured":"Tsai MC, Spitale RC, Chang HY. Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res. 2011;71(1):3\u20137.","journal-title":"Cancer Res"},{"issue":"1","key":"3056_CR105","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.160247","volume":"7","author":"Q Cai","year":"2017","unstructured":"Cai Q, Wang Z, Wang S, Weng M, Zhou D, Li C, et al. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1\u03b1 via miR-138. Open Biol. 2017;7(1): 160247.","journal-title":"Open Biol"},{"issue":"2","key":"3056_CR106","first-page":"127","volume":"6","author":"Y Li","year":"2016","unstructured":"Li Y, Chen P, Zu L, Liu B, Wang M, Zhou Q. MicroRNA-338-3p suppresses metastasis of lung cancer cells by targeting the EMT regulator Sox4. Am J Cancer Res. 2016;6(2):127\u201340.","journal-title":"Am J Cancer Res"},{"issue":"4","key":"3056_CR107","doi-asserted-by":"publisher","first-page":"BSR20194444","DOI":"10.1042\/BSR20194444","volume":"40","author":"L Liu","year":"2020","unstructured":"Liu L, Yan Y, Zhang G, Chen C, Shen W, Xing P. Knockdown of LINC01694 inhibits growth of gallbladder cancer cells via miR-340-5p\/Sox4. Biosci Rep. 2020;40(4):BSR20194444.","journal-title":"Biosci Rep"},{"key":"3056_CR108","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109774","volume":"123","author":"S Ghafouri-Fard","year":"2020","unstructured":"Ghafouri-Fard S, Esmaeili M, Taheri M. H19 lncRNA: Roles in tumorigenesis. Biomed Pharmacother. 2020;123: 109774.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"3056_CR109","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-016-0436-6","volume":"35","author":"SH Wang","year":"2016","unstructured":"Wang SH, Ma F, Tang ZH, Wu XC, Cai Q, Zhang MD, et al. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer. J Exp Clin Cancer Res. 2016;35(1):160.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7","key":"3056_CR110","doi-asserted-by":"publisher","first-page":"9721","DOI":"10.1007\/s13277-016-4852-1","volume":"37","author":"SH Wang","year":"2016","unstructured":"Wang SH, Wu XC, Zhang MD, Weng MZ, Zhou D, Quan ZW. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2. Tumour Biol. 2016;37(7):9721\u201330.","journal-title":"Tumour Biol"},{"issue":"11","key":"3056_CR111","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1101\/gr.122358.111","volume":"21","author":"T Gutschner","year":"2011","unstructured":"Gutschner T, Baas M, Diederichs S. Noncoding RNA gene silencing through genomic integration of RNA destabilizing elements using zinc finger nucleases. Genome Res. 2011;21(11):1944\u201354.","journal-title":"Genome Res"},{"issue":"2","key":"3056_CR112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188502","volume":"1875","author":"B Goyal","year":"2021","unstructured":"Goyal B, Yadav SRM, Awasthee N, Gupta S, Kunnumakkara AB, Gupta SC. Diagnostic, prognostic, and therapeutic significance of long non-coding RNA MALAT1 in cancer. Biochim Biophys Acta Rev Cancer. 2021;1875(2): 188502.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"12","key":"3056_CR113","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1111\/jcmm.12920","volume":"20","author":"SH Wang","year":"2016","unstructured":"Wang SH, Zhang WJ, Wu XC, Weng MZ, Zhang MD, Cai Q, et al. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer. J Cell Mol Med. 2016;20(12):2299\u2013308.","journal-title":"J Cell Mol Med"},{"issue":"25","key":"3056_CR114","doi-asserted-by":"publisher","first-page":"37857","DOI":"10.18632\/oncotarget.9347","volume":"7","author":"SH Wang","year":"2016","unstructured":"Wang SH, Zhang WJ, Wu XC, Zhang MD, Weng MZ, Zhou D, et al. Long non-coding RNA Malat1 promotes gallbladder cancer development by acting as a molecular sponge to regulate miR-206. Oncotarget. 2016;7(25):37857\u201367.","journal-title":"Oncotarget"},{"issue":"18","key":"3056_CR115","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.7150\/jca.46351","volume":"11","author":"S Liu","year":"2020","unstructured":"Liu S, Chu B, Cai C, Wu X, Yao W, Wu Z, et al. DGCR5 Promotes gallbladder cancer by sponging MiR-3619-5p via MEK\/ERK1\/2 and JNK\/p38 MAPK pathways. J Cancer. 2020;11(18):5466\u201377.","journal-title":"J Cancer"},{"issue":"1","key":"3056_CR116","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12943-019-1097-9","volume":"18","author":"YP Hu","year":"2019","unstructured":"Hu YP, Jin YP, Wu XS, Yang Y, Li YS, Li HF, et al. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p\/SET\/AKT axis. Mol Cancer. 2019;18(1):167.","journal-title":"Mol Cancer"},{"issue":"1","key":"3056_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2014.541","volume":"6","author":"MZ Ma","year":"2015","unstructured":"Ma MZ, Chu BF, Zhang Y, Weng MZ, Qin YY, Gong W, et al. Long non-coding RNA CCAT1 promotes gallbladder cancer development via negative modulation of miRNA-218-5p. Cell Death Dis. 2015;6(1): e1583.","journal-title":"Cell Death Dis"},{"key":"3056_CR118","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.2147\/OTT.S236350","volume":"13","author":"F Yang","year":"2020","unstructured":"Yang F, Tang Z, Duan A, Yi B, Shen N, Bo Z, et al. Long Noncoding RNA NEAT1 upregulates survivin and facilitates gallbladder cancer progression by sponging microRNA-335. Onco Targets Ther. 2020;13:2357\u201367.","journal-title":"Onco Targets Ther"},{"key":"3056_CR119","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2020.4290","author":"T Zhang","year":"2020","unstructured":"Zhang T, Chen L, Xu X, Shen C. Knockdown of long noncoding RNA urothelial carcinoma-associated 1 represses gallbladder cancer advancement by regulating SPOCK1 expression through sponging miR-613. Cancer Biother Radiopharm. 2020. https:\/\/doi.org\/10.1089\/cbr.2020.4290.","journal-title":"Cancer Biother Radiopharm"},{"issue":"10","key":"3056_CR120","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.15252\/embr.201744147","volume":"18","author":"XS Wu","year":"2017","unstructured":"Wu XS, Wang F, Li HF, Hu YP, Jiang L, Zhang F, et al. LncRNA-PAGBC acts as a microRNA sponge and promotes gallbladder tumorigenesis. EMBO Rep. 2017;18(10):1837\u201353.","journal-title":"EMBO Rep"},{"issue":"14","key":"3056_CR121","first-page":"7598","volume":"24","author":"XF Liu","year":"2020","unstructured":"Liu XF, Wang K, Du HC. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p. Eur Rev Med Pharmacol Sci. 2020;24(14):7598\u2013611.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"3056_CR122","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.biopha.2017.01.150","volume":"88","author":"F Ma","year":"2017","unstructured":"Ma F, Wang SH, Cai Q, Jin LY, Zhou D, Ding J, et al. Long non-coding RNA TUG1 promotes cell proliferation and metastasis by negatively regulating miR-300 in gallbladder carcinoma. Biomed Pharmacother. 2017;88:863\u20139.","journal-title":"Biomed Pharmacother"},{"key":"3056_CR123","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/1476-4598-13-156","volume":"13","author":"MZ Ma","year":"2014","unstructured":"Ma MZ, Li CX, Zhang Y, Weng MZ, Zhang MD, Qin YY, et al. Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer. Mol Cancer. 2014;13:156.","journal-title":"Mol Cancer"},{"key":"3056_CR124","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.674653","volume":"12","author":"S Wang","year":"2021","unstructured":"Wang S, Wang Y, Wang S, Tong H, Tang Z, Wang J, et al. Long non-coding RNA FIRRE acts as a miR-520a-3p sponge to promote gallbladder cancer progression via Mediating YOD1 expression. Front Genet. 2021;12: 674653.","journal-title":"Front Genet"},{"issue":"18","key":"3056_CR125","doi-asserted-by":"publisher","first-page":"5361","DOI":"10.1158\/0008-5472.CAN-15-3047","volume":"76","author":"MZ Ma","year":"2016","unstructured":"Ma MZ, Zhang Y, Weng MZ, Wang SH, Hu Y, Hou ZY, et al. Long noncoding RNA GCASPC, a target of miR-17-3p, negatively regulates pyruvate carboxylase-dependent cell proliferation in gallbladder cancer. Cancer Res. 2016;76(18):5361\u201371.","journal-title":"Cancer Res"},{"key":"3056_CR126","doi-asserted-by":"publisher","first-page":"8047","DOI":"10.2147\/OTT.S212231","volume":"12","author":"K Li","year":"2019","unstructured":"Li K, Tang J, Hou Y. LncRNA GATA6-AS inhibits cancer cell migration and invasion in gallbladder cancer by downregulating miR-421. Onco Targets Ther. 2019;12:8047\u201353.","journal-title":"Onco Targets Ther"},{"issue":"1","key":"3056_CR127","doi-asserted-by":"publisher","first-page":"5492","DOI":"10.1038\/s41467-019-13420-x","volume":"10","author":"S Xu","year":"2019","unstructured":"Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, et al. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nat Commun. 2019;10(1):5492.","journal-title":"Nat Commun"},{"key":"3056_CR128","doi-asserted-by":"publisher","first-page":"6219","DOI":"10.2147\/CMAR.S323759","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Tian M, Zhang D, Zhuang Y, Li Z, Xie S, et al. Long Non-coding RNA myosin light chain kinase antisense 1 plays an oncogenic role in gallbladder carcinoma by promoting chemoresistance and proliferation. Cancer Manag Res. 2021;13:6219\u201330.","journal-title":"Cancer Manag Res"},{"issue":"1","key":"3056_CR129","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.18632\/oncotarget.22846","volume":"9","author":"Z Xu","year":"2017","unstructured":"Xu Z, Yan Y, Zeng S, Dai S, Chen X, Wei J, et al. Circular RNAs: clinical relevance in cancer. Oncotarget. 2017;9(1):1444\u201360.","journal-title":"Oncotarget"},{"issue":"16","key":"3056_CR130","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100836","volume":"38","author":"IL Patop","year":"2019","unstructured":"Patop IL, W\u00fcst S, Kadener S. Past, present, and future of circRNAs. EMBO J. 2019;38(16): e100836.","journal-title":"EMBO J"},{"key":"3056_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2019.102854","volume":"145","author":"P Naeli","year":"2020","unstructured":"Naeli P, Pourhanifeh MH, Karimzadeh MR, Shabaninejad Z, Movahedpour A, Tarrahimofrad H, et al. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Crit Rev Oncol Hematol. 2020;145: 102854.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"3056_CR132","first-page":"547","volume":"18","author":"X Meng","year":"2017","unstructured":"Meng X, Li X, Zhang P, Wang J, Zhou Y, Chen M. Circular RNA: an emerging key player in RNA world. Brief Bioinform. 2017;18(4):547\u201357.","journal-title":"Brief Bioinform"},{"issue":"1","key":"3056_CR133","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13045-016-0370-2","volume":"10","author":"Y Dong","year":"2017","unstructured":"Dong Y, He D, Peng Z, Peng W, Shi W, Wang J, et al. Circular RNAs in cancer: an emerging key player. J Hematol Oncol. 2017;10(1):2.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"3056_CR134","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.bbrc.2018.06.088","volume":"503","author":"D Kai","year":"2018","unstructured":"Kai D, Yannian L, Yitian C, Dinghao G, Xin Z, Wu J. Circular RNA HIPK3 promotes gallbladder cancer cell growth by sponging microRNA-124. Biochem Biophys Res Commun. 2018;503(2):863\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3056_CR135","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3892\/ol.2021.12824","volume":"22","author":"P Wang","year":"2021","unstructured":"Wang P, Zhou C, Li D, Zhang D, Wei L, Deng Y. circMTO1 sponges microRNA-219a-5p to enhance gallbladder cancer progression via the TGF-\u03b2\/Smad and EGFR pathways. Oncol Lett. 2021;22(1):563.","journal-title":"Oncol Lett"},{"issue":"16","key":"3056_CR136","first-page":"8359","volume":"24","author":"X Wang","year":"2020","unstructured":"Wang X, Lin YK, Lu ZL, Li J. Circular RNA circ-MTO1 serves as a novel potential diagnostic and prognostic biomarker for gallbladder cancer. Eur Rev Med Pharmacol Sci. 2020;24(16):8359\u201366.","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-03056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-022-03056-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-022-03056-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T06:37:43Z","timestamp":1684737463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-022-03056-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,28]]},"references-count":136,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["3056"],"URL":"https:\/\/doi.org\/10.1007\/s12094-022-03056-7","relation":{},"ISSN":["1699-3055"],"issn-type":[{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,28]]},"assertion":[{"value":"11 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}